• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment


160.8700 USD 0.9600 0.60%

As of 17:20:00 ET on 08/01/2014.

Snapshot for Illumina Inc (ILMN)

Open: 160.4200 Day's Range: 157.5250 - 161.3160 Volume: 1,021,787
Previous Close: 159.9100 52wk Range: 72.7700 - 185.0000 1-Yr Rtn: +102.48%

Stock Chart for ILMN

No chart data available.
  • ILMN:US 160.8100
  • 1D
  • 1M
  • 1Y
Interactive ILMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILMN

Current P/E Ratio (ttm) 100.4336
Estimated P/E(12/2014) 70.2796
Relative P/E vs. SPX 5.7141
Earnings Per Share (USD) (ttm) 1.6018
Est. EPS (USD) (12/2014) 2.2890
Est. PEG Ratio 3.2304
Market Cap (M USD) 22,425.28
Shares Outstanding (M) 139.40
30 Day Average Volume 1,298,531
Price/Book (mrq) 19.1179
Price/Sale (ttm) 12.7557
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILMN

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil